In the U.S., EndeavorRx has been cleared to help in improving attention function as measured by computer-based testing in children ages 8-12 years who have primarily inattentive or combined-type ADHD who struggle with maintaining attention. A study published in the medical journal PLOS ONE found that the EndeavorRx video game treatment from Akili Interactive Labs improved brain function for pediatric patients with ADHD, the company announced recently. Akili expects to launch the treatment in the second half of this year.